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THE imbalance of T-helper (Th) lymphocyte cytokine
production may play an important role in immuno-
pathogenesis  of  persistent  hepatitis  C  virus  (HCV)
infection.  To  know  whether  an  imbalance  between
Th1  and  Th2  cytokines  is  present  in  chronic  HCV
infection, serum levels of Th1 cytokines, interferon
gamma (IFN-g ) and interleukin (IL)-2, and Th2 cyto-
kines, IL-4 and IL-10, were measured using enzyme-
linked immunosorbent assay in this study. Eighteen
individuals  with  chronic  HCV  infection,  11  healthy
subjects  as  normal  controls  and  10  chronic  HBV
infected patients as disease controls were observed.
The results showed that the levels of Th2 cytokines
(IL-4  and  IL-10)  were  significantly  increased  in
chronic HCV infected patients compared with normal
controls (IL-4: 30.49 ± 17.55 vs. 14.94 ± 13.73, pg/ml,
P<0.025; IL-10: 50.30 ± 19.59 vs. 17.87 ± 9.49, pg/ml,
P<0.001). Similarly, the levels of Th1 cytokine, IL-2,
was  also  elevated  in  individuals  with  chronic  HCV
infection when compared with normal controls (IL-2:
118.53  ±  95.23  vs.  61.57  ±  28.70,  pg/ml,  P<0.05).
However,  Th1  cytokine  IFN-g level  was  not  sig-
nificantly changed during HCV infection (IFN-g : 28.09
±  15.65  vs.  24.10  ±  15.61,  pg/ml,  P>0.05).  Fur-
thermore,  the  elevated  levels  of  Th2  cytokines  are
greater than Th1 cytokines in HCV infection.  Thus,
the study indicates that an enhanced Th2 responses
are present during chronic HCV infection, which may
partly  be  responsible  for  the  persistence  of  HCV
infection.
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Introduction
Hepatitis  C  virus  (HCV)  infection  has  been  con-
firmed  to  be  the  major  aetiologic  agent  for  post-
transfusion hepatitis all over the world. One of the
characteristic features is at least half of the infection
to  become  chronic.
1–3 The  high  mutational  rate  of
the viral genome is considered to be responsible for
persistent  HCV  infection.
3 The  inability  of  the  host
immune  function  to  eliminate  an  organism  is  also
an  important  cause  for  persistentive  form  of
infection.
4 However,  little  has  been  learned  about
the host cellular immune response to HCV . The role
of the immunoregulatory cytokines in chronic HCV
infection  is recently  being stressed.
5,6 In  this study,
to better know the profiles of cytokines production
in  individuals  with  chronic  HCV  infection,  we
measured  serum  levels  of  T-helper  lymphocytes
(Th)1  cytokines  interferon  gamma  (IFN-g ),  inter-
leukin  (IL)-2,  and Th2  cytokines  IL-4,  IL-10  in  such
patients.
Subjects and Methods
Subjects
Eighteen  patients with  chronic HCV  infection  were
included in this study. The diagnosis of chronic HCV
infection  was  based  on  the  seropositivity  of  HCV
specific antibody and HCV-RNA for at least 6 months
of  ‡   2  times  detection.  There  was  no  serologic
evidence  of  co-infection  with  other  hepatotropic
viruses.  Other  possible  causes  of  hepatocellular
injury,  such  as  alcohol,  drugs  and  autoimmune
diseases were  also excluded.  No  immunoregulatory
agents were administered in recent 3 months before
enrolment.  The  characteristics  of  18  chronic  HCV
infected individuals were summarized in Table 1.
As normal controls, 11 healthy subjects who were
negative  for  both  serum  anti-HCV  and  hepatitis  B
virus (HBV) markers were selected without a clinical
history of hepatitis and without symptoms or signs of
liver diseases (seven males and four females; mean age
32  years,  range  20–47  years).  Also,  10  chronic
0962-9351/98/040295-03 $9.00 © 1998 Carfax Publishing Ltd 295
Short Communication
Mediators of Inflammation, 7, 295–297 (1998)hepatitis B patients (seven males and three females,
mean  age  38  years,  range  23–56  years)  with  no
serologic evidence of HCV infection were recruited as
disease  controls,  who  had  seropositivity  of  HBV
markers  and  abnormal  liver  tests  for  more  than  6
months.
Methods
Serologic  detections  of  HBV  markers,  anti-HCV  (a
second-generation test) were carried out using com-
mercially  available  enzyme-linked  immunosorbent
assay (ELISA) kits (Sino-American Biotechnology Com-
pany,  Louyan,  China).  The  procedures  were  per-
formed according to the manufacturer’s instruction.
Serum  HCV-RNA  was  determined  by  reverse  tran-
scription polymerase chain reaction (RT-PCR). Briefly,
RNA was extracted from the samples by single step
method  as  described  previously.
7 The  amplification
was  done  after  an  initial  denaturation  step  (94°C,
5 min)  by  32  cycles  (94°C,  30 s;  58°C,  30 s;  72°C,
1 min) and 5 min at 72°C in a thermocycler (Perkin-
Elmer  Cetus,  Changsha  Branch,  Changsha,  China).
The  amplified  cDNA  fragments  were  analysed on  a
1.5%  agarose  gel.  The  bands  were  visualized  by
ethidium bromide staining.
Quantification of serum cytokines was measured by
ELISA  using  commercially  available  kits  (Genzyme,
Shenzheng Branch, Shenzheng, China). The sera were
stored at  –30°C until assay  (in 3  months) and  each
sample was examined in duplicate. The assays were
performed following the manufacturer’s instruction.
Statistics
Data  were  analysed  by  non-parametric  test  and
expressed as mean ± standard division.
Results
The serum levels of IFN-g , IL-2, IL-4 and IL-10 were
measured in patients with HCV or HBV infection and
normal controls. As shown in Table 2, Th2 cytokines
(IL-4 and IL-10) levels were significantly increased in
chronic HCV infected patients compared with normal
controls (P<0.025,  P<0.001).  Similarly,  the levels of
the Th1 cytokine, IL-2, was also elevated in individuals
with  chronic  HCV  infection  when  compared  with
normal  controls  (P<0.05).  However,  Th1  cytokine
IFN-g level was not significantly changed during HCV
infection (P>0.05).
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Table 1. Details of individuals with chronic HCV infection
Patient Sex
(F/M)
Age
(years)
Blood transfusion
history (time)
Anti-HCV HCV-RNA ALT(U/L)*
1 F 30 yes (1995) + + 150
2 F 23 no + + <40
3 M 68 yes (1995) + + 138
4 M 40 yes (1993) + + 184
5 M 42 yes (1989) + + 66
6 F 27 yes (1990) + + 180
7 M 58 yes (1995) + + 158
8 M 49 yes (1992) + + 252.2
9 F 51 yes (1991) + + <40
10 F 61 yes (1989) + + <40
11 M 26 yes (1995) + + 60.5
12 M 44 yes (1992) + + 760
13 M 45 yes (1993) + + 48.5
14 F 28 yes (1994) + + 74.3
15 M 38 yes (1994) + + 742
16 M 43 yes (1994) + + 48
17 F 54 yes (1990) + – 71.7
18 F 66 yes (1990) + + 129.8
*ALT: alanine transaminase, normal value £  40U/l.
Table 2. The comparison of serum cytokines in three studied groups
IFN-g (pg/ml) IL-2 (pg/ml) IL-4 (pg/ml) IL-10 (pg/ml)
Control 24.10 ± 15.61 61.57 ± 28.70 14.94 ± 13.73 17.87 ± 9.49
HBV infection 32.48 ± 19.99 56.75 ± 20.04 21.44 ± 11.23 31.16 ± 17.15**
HCV infection 28.09 ± 15.65 118.53 ± 95.23* 30.49 ± 17.55** 50.30 ± 19.59***
*,**,***: P values <0.05, <0.025, <0.001 compared with normal controls respectively.In chronic HBV infected patients, serum levels of
IFN-g , IL-4 and IL-10 were higher than those in normal
controls, though only IL-10 level reached a statistical
difference (Table 2). Furthermore, the elevated level
of serum IL-10 was smaller in HBV infected patients
compared with that in HCV infected patients.
The serum levels of IFN-g , IL-2, IL-4 and IL-10 have
not  been  found  to  be  related  to  serum  activity  of
alanine transaminase (ALT) in  HCV infected individ-
uals (Table 3).
Discussion
It has been demonstrated that Th lymphocytes may be
subdivided  into  Th1  and  Th2  cells  based  on  the
distinct  patterns  of  cytokine  production.
8 Th1  cells
produce IFN-g , IL-2 and lymphotoxin which promote
cell-mediated  effector  responses;  whereas Th2  cells
produce  IL-4,  IL-5,  IL-6  and  IL-10  cytokines  which
influence  B-cell  development  and  can  augment
humoral responses. Cytokines released by one type of
Th  lymphocyte  population  can  down-regulate  the
functions of another Th population. Th1 responses are
associated with immunity  or resistance to infection,
while Th2 responses are associated with the progres-
sion or persistence of infection.
9,10 A shift of Th1 to
Th2 responses has been implicated in the pathogene-
sis  of  some  infectious  diseases,  such  as  human
immunodeficiency virus infection, mycobacterial and
protozoal diseases.
4,10
Inflammatory cytokines play an important  role in
pathogenesis  of hepatitis B.
11 However, the reports
on the manner of cytokines in chronic HCV infection
are rare. The current study showed that the increased
production of Th1 (IFN-g and IL-2) and Th2 (IL-4 and
IL-10) cytokines are present in HCV infection, suggest-
ing  Th  cells  are  activated  in  vivo due  to  HCV
infection. This results is in  agreement  with  another
observation reported by Cacciarelli.
6 It is also noted
that the elevated levels of Th2 cytokines are greater
than  Th1  cytokines  in  HCV  infection.  In  view  of
negative  regulation  of  Th2  cytokines  for  immune
functions,
4 we consider that enhanced Th2 reaction is
at least partly responsible for immunopathogenesis of
chronic  HCV  infection.  We  also  propose  that
enhanced Th2 responses in HCV infection may allow
the  human  host  to  suppress  the  inflammatory/
immune  responses,
12,13 resulting  in  reducing  the
hepatic tissue injury through down-regulation of the
inflammatory/immune reaction and leading to inabil-
ity  to  eliminate  the  virus.  This  is  one  possible
explanation why HCV infection tends to be a chronic
condition.  To  further  elucidate  the  role  of  these
cytokines  in  immunopathogenesis  of  chronic  HCV
infection,  the  levels  of  mRNA  expression  for  intra-
hepatic Th cytokines are currently performing.
Similarly,  an  increased  production  of  IL-10  was
observed  for  chronic  HBV  infection  in  the  study.
Based  on  the  results  in  this  study,  enhanced  Th2
responses,  however,  are  obviously  weaker  in  HBV
infection than in HCV infection. It is possibly one of
the causes that the chronic feature is more common
in HCV infection than in HBV infection.
References
1. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al.
Interrelationship  of  blood  transfusion,  non-A,  non-B  hepatitis  and
hepatocellular carcinoma: analysis by detection of antibody to hepatitis
C virus. Hepatology 1990; 12: 671–675.
2. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G,
et al. Evidence for immune selection of hepatitis C virus (HCV) putative
envelope glycoprotein variants: potential role in chronic HCV infections.
Proc Natl Acad Sci USA 1992; 89: 3468–3472.
3. Iwata K, Wakita T, Okumura A, Yoshioka K, Takayanago M, Wands JR, et al.
Interferon  gamma  production  by  peripheral  blood  lymphocytes  to
hepatitis  C  virus  core  protein  in  chronic  hepatitis  C  infection.
Hepatology 1995; 22: 1057–1064.
4. Modlin  RL,  Nutman  TB.  Type  2  cytokines  and  negative  immune
regulation  in  human  infections.  Curr  Opin  Im munol 1993;  5:
511–514.
5. Bertoletti A, D’Elios MM, Boli C, Carli MD, Zignego AL, Durazzo M, et al.
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B
and  hepatitis  C  virus  infections.  Gastroenterology 1997;  112:
193–199.
6. Cacciarelli  TV,  Martinez  OM,  Gish  RG,  Villanueva  JC,  Krams  SM.
Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-
and posttreatment with interferon alfa. Hepatology 1996; 24: 6–9.
7. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid
guanidinium  thiocyanate-phenol-chloroform  extraction.  Ann  Biochem
1987; 162: 156–158.
8. Fan XG, Yakoob J, Fan XJ, Keeling PWN. Effect of IL-4 on peripheral blood
lymphocyte  proliferation:  implication  in  immunopathogenesis  of  H.
pylori infection. Im munol Lett 1995; 48: 45–48.
9. Fan  XG,  Yakkob  J,  Fan  XJ,  Keeling  PWN.  Enhanced  Th2  responses:
immune  mechanism  of  H.  pylori infection.  Ir  J  Med  Sci 1996;  165:
37–39.
10. Clerici M, Shearer GM. TH1-TH2 switch is a critical step in the etiology
of HIV infection. Im munol Today 1993; 14: 107–110.
11. Fan  XG,  Zhang  Z.  Increased  tumour  necrosis  factor  a production  by
neutrophils  in  patients  with  hepatitis  B.  J  Clin  Pathol 1994;  47:
616–618.
12. Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz
S, et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of
hepatitis  C  virus  antigens  and  their  relevance  during  the  course  of
chronic infection. Hepatology 1995; 21: 632–638.
13. Tsai SL, Liaw YF , Yeh CT, Chu CM, Kuo GC. Cellular immune responses in
patients with dual infection of hepatitis B and C viruses: dominant role
of hepatitis C virus. Hepatology 1995; 21: 908–912.
Received 16 March 1998;
accepted 8 May 1998
Circulating Th1 and Th2 cytokines in patients with HCV
Mediators of Inflammation · Vol 7 · 1998 297
Table 3. The relation of cytokines and ALT in HCV infection
ALT (U/L) IFN-g (pg/ml) IL-2 (pg/ml) IL-4 (pg/ml) IL-10 (pg/ml)
>100 25.94 ± 14.77 132.36 ± 107.08 36.71 ± 21.74 51.97 ± 24.46
£ 100 30.24 ± 16.20 104.71 ± 79.31 24.28 ± 8.11 48.63 ± 11.01
ALT: alanine transaminase, no significance difference in each group.